Summer semester 2024

General remarks

General lecture period summer semester 2024: 15.04.2024 to 12.07.2024 (with winter semester 2023/2024, 2nd exam period: 02.04. - 13.04.2024 (link CAU) - In accordance with the CAU's examination procedure regulations, there are no courses in bachelor's and master's degree programs during the examination periods (few exceptions for first semester students)).

More information at M. Sc. Biological Oceanography - information for students on OLAT.

Exam dates summer semester 2024: here (OLAT)

There is no general registration for courses - only for the exams at the end of the semester during registration phases (s.b.).

Notes on how to use the online tool can be found here:

If you have questions about the examination administration procedures in general (registration periods, examination periods, etc.) you may find answers in the Examination procedures section. If you are still unclear about anything you can contact the relevant Examination Office at any time.

Complete examination schedule SS 2024 (link to CAU).

Examinations:

Typical examination procedure:     

  1. Examination registration: You register for the examinations that you would like to take in the next examination period or that are assigned to the next examination period (s.b. Examination Organisation Online (CAU)). In case of registration problems contact the Examination Office Biology.

    During the registration period for the 1st examination period please register for all the written or oral examinations you would like to take in the 1st examination period (or around and assigned to the 1st examination period), but also for the examinations that you have already taken or started (e.g. seminar papers) during the lecture period (including before the registration period), as well as for examinations (e.g. assignments) that are to be taken during the lecture-free period.

    Note: For examinations taken before the registration period, examination attendance is considered as binding registration. You must also register for these examinations during the registration period, however, so that your academic achievements can be recorded in the system at a later stage.

  2. Checking admission: Two days before the start of the examination period, you check whether you have been granted admission to the examinations you have registered for.
  3. Examination attendance: You take the examinations during the examination period.
  4. Checking results: You check the results entered by the examiners.

Examination Organisation Online (CAU)

Access to the online tool in the CAU-Portal: http://www.uni-kiel.de/hisinone

The online tool has the following functions:

  • Registering for examinations / Cancelling registrations
  • Information on registered examinations (checking admissions. Information on examination dates, times and rooms)
  • Information on examination results
     

Notes on how to use the online tool can be found here:

You need your stu-ID to use the Studierenden-Online-Funktion online tool. Detailed information on the stu-ID and stu-e-mail address can be found at the Computing Centre StudiNet.

If you have questions about the examination administration procedures in general (registration periods, examination periods, etc.) you may find answers in the Examination procedures section. If you are still unclear about anything you can contact the Examination Office Biology at any time.

Registration period first exam phase summer semester: 03.06.2024 - 30.06.2024

First exam period summer semester: 15.07.2024 - 27.07.2024

Registration period second exam period summer semester: 26.08.2024 - 22.09.2024

Second exam period winter semester: 07.10.2024 - 19.10.2024 

Complete schedule see CAU website and here (link to CAU).

Keep in mind - it's your responsibility not to miss any fixed dates and/or deadlines.

Practical courses, practical exercises and some seminars have compulsory attendance (FPO).

Make sure that you sign the attendance list every course day!

Framework of courses:

  1. All of the five first semester modules are compulsory.
  2. Passed core modules of the first semester (MNF-bioc-101 and MNF-bioc-102) are important for the understanding for the advanced modules of the second semester in summer (e.g. MNF-bioc-201 and MNF-bioc-202).
  3. Passed exams of ALL compulsory modules of first and second semester are the  indispensable prerequisite for the exam of the core module of third semester in winter (MNF-bioc-301).
  4. A short presentation of your planned master's thesis ("proposal day") and a passed exam at the end of MNF-bioc-301 is the prerequisite to register your thesis (MNF-bioc-401) at the examination office.

For details concerning exams, prerequisites etc. look at the exam regulations in Biological Oceanography (p. 10-13).

Forms concerning exam withdrawal for good cause, medical certificate etc. (forms).

General regulations concerning examinations can be found here.

Considerations concerning using first or second exam phase (CAU).

Exams are generally scheduled only for the semester where the modules are taught.

  • There are no exams for winter semester modules MNF-bioc-1xx and MNF-bioc-3xx in summer semester.
  • There are no exams for summer semester modules MNF-bioc-2xx in winter semester.

Examination Schedule (lecturers and students tasks (link to CAU)

Timetables and course lists

General: Courses (lectures, seminars, practicals etc.) summer semester 2024

MSc. Biological Oceanography - second semester - lecture plan summer semester 2024 (click on "Stundenplan" for a complete time table).  All seven different possible practical parts in three blocks of MNF-bioc-202 are shown which looks heavily loaded - but you have to choose only two resp. three non overlapping parts.

Details: More detailed information concerning single courses and modules can be found on OLAT in general, resp. M. Sc. Biological Oceanography - information for students or via our module list, with links to the resp. module information on OLAT.

As you can take many optional modules outside of our curriculum (CAU-wide choices) these are not included in the example lists and timetables.

Block courses in summer 2024: 

  • MNF-bioc-264 (S. Garthe, Büsum): September/October 2024
  • MNF-bioc-271 (B. Schneider, Kiel): 21.05.2024 - 24.05.2024
  • MNF-bioc-280 (K. Heubel, FTZ): 26.08.2024 - 06.09.2024 at FTZ Büsum.
  • MNF-bioc-301 (F. Mittermayer, ALKOR cruise MNF-bioc-301): 18.08.2024 - 30.08.2024
  • MNF-bioc-368 (F. Weinberger, Aaland-Island (Finland) - Marine station Husö): 07.09.2024 - 22.09.2024

  • For optional modules within Biological Oceanography look at the module list.
  • Generally: for imported courses (e.g. Introduction to Physical Oceanography) and and courses outside of M. Sc. Biological Oceanography please always contact the person in charge of the module you are attending and the corresponding exam office.
  • For a selection of courses outside of our curriculum look here (optional courses outside of Biological Oceanography).

 

Summer semester 2024

UnivIS
Informationssystem der Universität Kiel © Config eG 
Semester: SS 2024 

Pieters R ; Schrappe, Martin ; De Lorenzo P ; Hann I ; De Rossi G ; Felice M ; Hovi L ; LeBlanc T ; Szczepanski T ; Ferster A ; Janka G, Rubnitz J ; Silverman L ; Stary J ; Campbell M ; Li CK ; Mann G ; Suppiah R ; Biondi A ; Vora A ; Valsecchi MG:
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. .
In: Lancet 370 (2007), Nr. 9583, S. 240-250

Krappmann P ; Paulides M ; Stöhr W ; Ittner E, ; Plattig B ; Nickel P ; Lackner H ; Schrappe, Martin ; Janka G ; Beck JD ; Langer T:
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. .
In: Pediatr Hematol Oncol 24 (2007), Nr. 2, S. 101-109

Mann G ; Attarbaschi A ; Burkhardt, Birgit ; Niggli F ; Klapper W ; Ludwig WD ; Schrappe, Martin ; Zimmermann M ; Gadner H, ; Reiter A ; Berlin-Frankfurt-Münster Group:
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma. .
In: Br J Haematol 138 (2007), Nr. 3, S. 443-449

Cario, Gunnar ; Izraeli S ; Teichert A ; Rhein P ; Skokowa J ; Möricke, Anja ; Zimmermann M ; Schrauder, Andre ; Karawajew L ; Ludwig WD ; Welte K ; Schünemann HJ ; Schlegelberger B ; Schrappe, Martin ; Stanulla, Martin:
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS .
In: J Clin Oncol 25 (2007), Nr. 30, S. 4813-4820

Jansen MW ; Corral L ; van der Velden VH ; Panzer-Grumayer R ; Schrappe, Martin ; Schrauder, Andre ; Marschalek R ; Meyer C ; den Boer ML ; Hop WJ ; Valsecchi MG ; Basso G ; Biondi A ; Pieters R ; van Dongen JJ:
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. .
In: Leukemia (2007),

Kager L ; Lion T ; Attarbaschi A ; Koenig M ; Strehl S ; Haas OA ; Dworzak MN ; Schrappe, Martin ; Gadner H ; Mann G ; Austrian BFM Study Group:
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. .
In: Haematologica 92 (2007), Nr. 11, S. 1561-4.

Stanulla, Martin ; Cario, Gunnar ; Meissner, Barbara ; Schrauder, Andre ; Möricke, Anja ; Riehm H ; Schrappe, Martin:
Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group. .
In: Blood Cells Mol Dis 39 (2007), Nr. 2, S. 160-163

Bornhauser BC ; Bonapace L ; Lindholm D ; Martinez R ; Cario, Gunnar ; Schrappe, Martin ; Niggli FK ; Schäfer BW ; Bourquin JP:
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway. .
In: Blood 110 (2007), Nr. 6, S. 2084-2091

Nachman JB ; Heerema NA, ; Sather H, ; Camitta B ; Forestier E ; Harrison CJ ; Dastugue N ; Schrappe, Martin ; Pui CH ; Basso G ; Silverman LB ; Janka-Schaub GE:
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. .
In: Blood 110 (2007), Nr. 4, S. 1112-1115

Conter V ; Valsecchi MG ; Silvestri D ; Campbell M ; Dibar E ; Magyarosy E ; Gadner H ; Stary J ; Benoit Y ; Zimmermann M ; Reiter A ; Riehm H ; Masera G ; Schrappe, Martin:
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial .
In: Lancet 369 (2007), Nr. 9556, S. 123-31

Stanulla, Martin ; Dynybil C ; Bartels DB ; Dördelmann M ; Löning L ; Claviez, Alexander ; Schrappe, Martin ; ALL-BFM study group:
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group. .
In: Haematologica 92 (2007), Nr. 11, S. 1581-82

Breit S ; Stanulla M ; Flohr T ; Schrappe, Martin ; Ludwig WD ; Tolle G ; Happich M ; Muckenthaler MU ; Kulozik AE:
Activating NOTCH1 mutations predict favorable early treatment response and long term outcome in child-hood precursor T-cell lymphoblastic leukemia. .
In: Blood. 2006 108 (2006), Nr. 4, S. 1151-7

Staal FJ ; Cario, Gunnar ; Cazzaniga G ; Haferlach T ; Heuser M ; Hofmann WK ; Mills K ; Schrappe, Martin ; Stanulla M ; Wingen LU ; van Dongen JJ ; Schlegelberger B:
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks .
In: Leukemia. 20 (2006), Nr. 8, S. 1385-92

Meyer LH, , , , , . ; Karawajew L ; Schrappe, Martin ; Ludwig WD ; Debatin KM ; Stahnke K:
Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL. .
In: Blood 107 (2006), Nr. 11, S. 4524-31

Maecker B ; Mougiakakos D ; Zimmermann M ; Behrens M ; Hollander S ; Schrauder, Andre ; Schrappe, Martin ; Welte K ; Klein C:
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. .
In: Leukemia 20 (2006), Nr. 4, S. 645-9

Gast A ; Bermejo JL ; Flohr, Thomas ; Stanulla M ; Burwinkel B ; Schrappe, Martin ; Bartram CR ; Hemminki K ; Kumar R:
Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study .
In: Leukemia (2006),

Burkhardt B ; Woessmann W ; Zimmermann M ; Kontny U ; Vormoor J ; Doerffel W ; Mann G ; Henze G ; Niggli F ; Ludwig WD ; Janssen D ; Riehm H ; Schrappe, Martin ; Reiter A:
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. .
In: J Clin Oncol 24 (2006), Nr. 3, S. 491-9

Neudenberger J ; Hotfilder M ; Rosemann A ; Langebrake C ; Reinhardt D ; Pieters R ; Schrauder, Andre ; Schrappe, Martin ; Rottgers S ; Harbott J ; Vormoor J:
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11). .
In: Br J Haematol. 133 (2006), Nr. 3, S. 337-44

Markus M ; Mann G ; Monschein U ; Lodzinski M ; Gall C ; Flohr T ; Viehmann S ; Langer T ; Schrappe, Martin ; Gadner H ; Haas OA ; Panzer-Grumayer ER:
Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene. .
In: Haematologica 95 (2006), Nr. 5, S. 683-6

Kratz CP ; Boll S ; Kontny U ; Schrappe, Martin ; Niemeyer CM ; Stanulla M:
Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia .
In: Leukemia 20 (2006), Nr. 2, S. 381-3

Möricke, Anja ; Zimmermann M ; Reiter A ; Gadner H ; Odenwald E ; Harbott J ; Ludwig WD ; Riehm H ; Schrappe, Martin:
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. .
In: Klin Padiatr 217 (2006), Nr. 6, S. 310-20

Claviez, Alexander ; Eckert C ; Seeger K, ; Schrauder, Andre ; Schrappe, Martin ; Henze G ; von Stackelberg A:
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. .
In: Haematologica 91 (2006), Nr. 2, S. 272-3

Schrauder, Andre ; Reiter A ; Gadner H ; Niethammer D ; Klingebiel T ; Kremens B ; Peters C ; Ebell W ; Zimmermann M ; Niggli F ; Ludwig WD ; Riehm H ; Welte K ; Schrappe, Martin:
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95 .
In: Journal of Clinical Oncology 24 (2006), Nr. 36, S. 5742-9

Gadner H ; Masera G ; Schrappe, Martin ; Eden T ; Benoit Y ; Harrison C ; Nachman J ; Pui CH:
The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005. .
In: Leukemia 20 (2006), Nr. 1, S. 9-17

Meyer C ; Schneider B ; Jakob S ; Strehl S ; Attarbaschi A ; Schnittger S ; Schoch C ; Jansen MW ; van Dongen JJ ; den Boer ML ; Pieters R ; Ennas MG ; Angelucci E ; Koehl U ; Greil J ; Griesinger F ; Zur Stadt U ; Eckert C ; Szczepanski T ; Niggli FK ; Schafer BW ; Kempski H ; Brady HJ ; Zuna J ; Trka J ; Nigro LL ; Biondi A ; Delabesse E ; Macintyre E ; Stanulla M ; Schrappe, Martin ; Haas OA ; Burmeister T ; Dingermann T ; Klingebiel T ; Marschalek R:
The MLL recombinome of acute leukemias. .
In: Leukemia 20 (2006), Nr. 5, S. 777-84

Lauten M ; Schrauder, Andre ; Kardinal C ; Harbott J ; Welte K ; Schlegelberger B ; Schrappe, Martin ; von Neuhoff N:
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance. .
In: Leukemia. 2006 May;20(5):820-6. 20 (2006), Nr. 5, S. 820-6

Schrappe, Martin ; Harbott, J. ; Riehm, H.:
Akute lymphoblastische Leukämien .
In: Gadner, Helmut ; Gaedicke, Gerhard ; Niemeyer, Charlotte ; Ritter, Jörg (Hrsg.) : Pädiatrische Hämatologie und Onkologie.
Heidelberg : Springer, 2005, S. 656-679. - ISBN 3-540-03702-0

Balduzzi A ; Valsecchi MG ; Uderzo C ; De Lorenzo P ; Klingebiel T ; Peters C ; Stary J ; Felice MS ; Magyarosy E ; Conter V ; Reiter A ; Messina C ; Gadner H ; Schrappe, Martin:
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study .
In: Lancet 366 (2005), Nr. 9486, S. 635-42

Einsiedel HG ; von Stackelberg A ; Hartmann R ; Fengler R ; Schrappe, Martin ; Janka-Schaub G ; Mann G ; Hahlen K ; Gobel U ; Klingebiel T ; Ludwig WD ; Henze G:
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87 .
In: J Clin Oncol. 23 (2005), Nr. 31, S. 7942-50

Einsiedel HG ; von Stackelberg A ; Hartmann R ; Fengler R ; Schrappe, Martin ; Janka-Schaub G ; Mann G ; Hahlen K ; Gobel U ; Klingebiel T ; Ludwig WD ; Henze G:
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. .
In: J Clin Oncol 23 (2005), Nr. 31, S. 7942-50

Berthold F ; Boos J ; Burdach S ; Erttmann R ; Henze G ; Hermann J ; Klingebiel T ; Kremens B ; Schilling FH ; Schrappe, Martin ; Simon T ; Hero B:
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial .
In: Lancet Oncol. 6 (2005), Nr. 9, S. 649-58

Möricke, Anja ; Zimmermann M ; Reiter A ; Gadner H ; Odenwald E ; Harbott J ; Ludwig WD ; Riehm H ; Schrappe, Martin:
Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95 = Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95 = [Alter als prognostischer Faktor bei Kindern und Jugendlichen mit akuter lymphoblastischer Leukämie : Ergebnisse aus den Therapiestudien ALL-BFM 86, 90 und 95] .
In: Klin Padiatr 217 (2005), Nr. 6, S. 310-320

Gadner H ; Masera G ; Schrappe, Martin ; Eden T ; Benoit Y ; Harrison C ; Nachman J ; Pui CH:
The eighth international childhood acute lymphoblastic leukemia workshop ('Ponte di Legno meeting') report: Vienna, Austria, April 27-28, 2005 .
In: Leukemia 19 (2005), Nr. 11, S. 1-9

Burkhardt B ; Zimmermann M ; Oschlies I ; Niggli F ; Mann G ; Parwaresch R ; Riehm H ; Schrappe, Martin ; Reiter A ; BFM Group:
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence .
In: Br J Haematol. 131 (2005), Nr. 1, S. 39-49

Teuffel O ; Schrauder, Andre ; Sykora KW ; Zimmermann M ; Reiter A ; Welte K ; Schrappe, Martin:
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia. .
In: Bone Marrow Transplant. 36 (2005), Nr. 2, S. 145-50

Arico M ; Baruchel A ; Bertrand Y ; Biondi A ; Conter V ; Eden T ; Gadner H ; Gaynon P ; Horibe K ; Hunger SP ; Janka-Schaub G ; Masera G ; Nachman J ; Pieters R ; Schrappe, Martin ; Schmiegelow K ; Valsecchi MG ; Pui CH:
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005 .
In: Leukemia 19 (2005), Nr. 7, S. 1145-52

Stanulla M ; Schaeffeler E ; Flohr T ; Cario, Gunnar ; Schrauder, Andre ; Zimmermann M ; Welte K ; Ludwig WD ; Bartram CR ; Zanger UM ; Eichelbaum M ; Schrappe, Martin ; Schwab M:
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia .
In: JAMA 293 (2005), Nr. 12, S. 1485-9

Machatschek JN ; Schrauder A ; Helm, Frank ; Schrappe, Martin ; Claviez, Alexander:
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literature .
In: Pediatr Hematol Oncol. 21 (2004), Nr. 7, S. 621-6

UnivIS ist ein Produkt der Config eG, Röttenbach
  • PD Dr. Frank Melzner
    Curriculum Coordinator
    Hohenbergstrasse 2
    Room 13
    Phone: +49 (0)431 600-4274
    E-mail: fmelzner(at)geomar.de

    Dr. Jörg Süling
    Study Coordinator
    Hohenbergstr. 2
    Room 006
    Phone: +49 (0)431 600-4454 / -4508
    E-mail: jsueling(at)geomar.de
    Consultation Tuesday 2-3 pm and Thursday 8-9 am - currently via zoom

    Annegret Stuhr
    Room 323
    Phone: +49 431 600-4028
    Email: astuhr(at)geomar.de

  • OLAT is the central online learning platform of CAU. On OLAT you always find recent material for lectures, seminars etc. 

  • Exam registration: If you encounter exam registration problems please contact exam office biology (Office Examination Board (web)).

    Generally: for imported courses and courses outside of M. Sc. Biological Oceanography please always contact the person in charge of the module you are attending and the corresponding exam office.

    Campusmanagementsystem

    Students service

  • Chairman of Examination Board

    Prof. Dr. Thorsten Reusch
    GEOMAR
    Helmholtz Centre for Ocean Research Kiel
    Düsternbrooker Weg 20
    24105 Kiel
    Room: A 31
    Phone: +49 431 600-4550
    E-Mail: treusch(at)geomar.de

    Office Examination Board (web)

    Marianne Lange  Tel. 0431/880-3724 (Raum E 50)
    Ines Wetzel   Tel. 0431/880-4157 (Raum E 51)

    Prüfungsamt Biologie
    Biozentrum
    Am Botanischen Garten 7
    24118 Kiel
    FAX 0431/880-5704

    pruefungsamt(at)bio.uni-kiel.de

  • Next application period: March 1 to April 15, 2025!

    More information at "how to aply"